Sandoz, US states strike $469m settlement in generic drug antitrust case
Sandoz and 43 attorneys struck a $469 million settlement agreement Monday to resolve antitrust claims accusing Sandoz of conspiring to fix prices, rig bids and allocate markets for generic drugs.Sandoz and...To view the full article, register now.
Already a subscriber? Click here to view full article